Notwithstanding the inconsistent results in the current literature regarding POT1 expression in cancer, it is conceivable that it may become useful to include measurements of POT1 expression in the routine molecular profiling of cancer for prognostic purposes and decisions about treatment intensity or modality. The gene discussed is POT1; the disease is cancer.